-
Additional manufacturing capacity for Comirnaty
Additional manufacturing capacity for Comirnaty
-
Additional manufacturing capacity for Comirnaty
Additional manufacturing capacity for Comirnaty
EMA recommends approval of additional manufacturing sites for Pfizer’s vaccine in Reinbek, Germany and in Stein, Switzerland
-
Management Board: Highlights of June 2021 meeting
Management Board: Highlights of June 2021 meeting
-
Management Board: Highlights of June 2021 meeting
Management Board: Highlights of June 2021 meeting
The Board was updated on EMA’s activities in response to the pandemic, the annual activity report for 2020 and progress with the clinical trial information system
-
Annual report 2020
Annual report 2020
-
Annual report 2020
Annual report 2020
EMA has published its 2020 annual report that provides an overview of the Agency’s major achievements, key figures and contributions to public health in Europe
-
PRAC highlights June 2021
PRAC highlights June 2021
-
PRAC highlights June 2021
PRAC highlights June 2021
Outcomes from the June meeting cover all aspects of the risk management of the use of medicines, including COVID-19 vaccines
